If you or a loved one was prescribed Zofran® (an anti-nausea drug) for morning sickness during pregnancy, and the child was later born with a birth defect, then this may be the most important message you will ever read...
Here is why...
Zofran® (ondansetron) is a prescription medication that is approved by the FDA to only treat vomiting and nausea in chemotherapy and postoperative surgery patients.
The FDA NEVER approved Zofran® (ondansetron) for treatment of morning sickness in pregnant women. Yet, the manufacturer of Zofran® (GlaxoSmithKline) began pushing this drug "off-label" to physicians treating pregnant mothers who were experiencing morning sickness.
So why did doctors think it was okay to prescribe Zofran® to pregnant mothers?
On July 2, 2012, The Justice Department announced that they had reached a $3 billion settlement with Zofran® manufacturer, GlaxoSmithKline (GSK) for illegal promotion of prescription drugs. It had been alleged that GlaxoSmithKline was paying kickbacks to doctors who prescribed Zofran®!
You see... drug manufacturers must adhere to strict rules set forth by the Food and Drug Administration (FDA). If they promote their drug to either doctors or patients as a remedy for a condition not yet approved by the FDA, that carries significant legal consequences... and more often than not inflicts tremendous pain on the victims who are prescribed these medications for uses it wasn't intended or test for.
There have been numerous research studies in the past few years that reveal Zofran® (ondansetron) use during pregnancy is linked to higher rates of birth defects.
In fact, researchers now believe (after analyzing the data), that Zofran® use is associated with a 30% INCREASED RISK of total birth defects in pregnancies, and a DOUBLED RISK of heart defects.
Unfortunately, the list of pregnancy risks associated with Zofran® is long. Below is a list of the most common birth defects linked to Zofran®:
As you can see, the birth risks with Zofran® are numerous and severe, and had GlaxoSmithKline kept Zofran® for the approved, intended uses, pregnant mothers should have NEVER BEEN PRESCRIBED this risky drug in the first place.
In August 2014, a study out of Sweden looking at nearly 900,000 pregnancies concluded that Zofran® (ondansetron) was linked with a doubled risk of heart defects.
Possible heart defects include...
A study published by the National Birth Defects Prevention Study (NBDPS), as well as a report published by the Center For Controlled Diseases (CDC) Nation Center on Birth Defects and Developmental Disabilities found that Zofran® taken during the first trimester of pregnancy doubles the risk of a cleft palate birth defect.
A cleft palate is a birth defect where the tissue that makes up the roof of the mouth (palate) does not join together during pregnancy. Normally the palate is formed between the sixth and ninth week of pregnancy, however Zofran® has been shown to increase the risk of the palate not developing as it should normally.
Very similar to the cleft palate birth defect, studies have shown that Zofran® use during pregnancy increases the risk of children developing a cleft lip.
A cleft lip occurs when the tissue that forms the lip does not join properly before birth. It appears as an opening, or gap, in the upper lip.
And because Zofran® has been shown to increase the risk of facial development defects, it is possible that a child have both a cleft palate and cleft lip.
Those who have suffered the pain of a child being born with a birth defect caused by Zofran® must know the differences and advantages of filing an individual Zofran® lawsuit compared to participating in a Zofran® class action lawsuit.
Our managing attorney, Andrew Bederman, will clearly explain the many reasons why an individually filed Zofran® lawsuit is typically more advantageous for victims of birth defects, as opposed to participating in a class action suit against Zofran® manufacturer, GlaxoSmithKline.
There are critical facts you need to be aware of when considering the choice between an individual or class action law suit, and our goal is to educate you on these crucial considerations so you can make the best decision for you and your family.
For a limited time, we are offering personal, one-on-one Zofran® lawsuit consultations with Greenberg & Bederman's managing attorney, Andy Bederman.
The legal consultation is 100% free. There are zero risks and absolutely no obligation to ever pay us or work with us. It's your risk-free chance to talk to an experienced lawyer who has practiced law for over 35 years.
But our free Zofran® lawsuit consultation is only available to family members of children who are victims of adverse birth defects that may have been caused by Zofran® use during pregnancy.
Fill out the contact form below, or call (800) 800-1144 right now to get started.
When you are ready to discuss your potential Zofran® lawsuit with a law firm, you want a lawyer that can clearly explain...
You will also be able to ask any questions you may have, too.
Please don't wait to contact us. There is a limited time window we will be offering free consultations with our managing attorney (and accepting cases).
We look forward to having a conversation with you. Fill out the form below to get started or simply call (800) 800-1144 right now.
Simply submit your information in the form below and one of our attorneys will contact you to discuss your potential case...
Or Call Now: (800) 800-1144
The Law Office of Greenberg & Bederman has numerous attorneys that were awarded the prestigious Super Lawyers™ status. Super Lawyers™ is an independent, attorney ranking organization that awards attorneys each year based on many factors, including affinity with other lawyers.
Copyright © 2022 Greenberg & Bederman, LLC.
All Rights Reserved.
Click to Scroll to Top of Page